[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
about
The bromodomain: from epigenome reader to druggable targetProtein lysine acetylation by p300/CBPNMR Fragment Screening Hit Induces Plasticity of BRD7/9 BromodomainsDiscovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsLP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorTargeting BET bromodomains for cancer treatmentLP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorBinding hotspots of BAZ2B bromodomain: Histone interaction revealed by solution NMR driven docking.Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk.Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.Discovery of a PCAF Bromodomain Chemical Probe.Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.Progress in the Development of non-BET Bromodomain Chemical Probes.Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development.Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.Structural features and inhibitors of bromodomains.9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomainSelective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations.Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.Chemical probes and inhibitors of bromodomains outside the BET family.What is the future of bromodomains in targeted drug development?A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations.Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites.Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity.Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomainsA poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc03115j.Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatographyDiscovery of a PCAF Bromodomain Chemical Probe
P2860
Q26999935-FB5F8DF9-E6B2-4868-B6A8-9DA4291FE328Q27021749-2F5C12E9-8232-4750-986E-6D99BDEB7316Q27704896-9F387823-A3F0-48B1-80FC-AFFDD0FD5278Q28242369-87905CA6-4868-4214-A4F4-62844A5ECD50Q28260305-809B71E8-C41A-441F-A7E5-8F5A75CD1DADQ28263519-F819876E-8074-4287-AC4F-90C64BDFC1CDQ28834025-FF3A95E5-447D-4DEB-86E3-9A847D652C91Q30855951-AE6C290A-2E0C-4684-B8D5-B4C8CFB5A756Q36012341-1636966D-3CBC-4153-86CB-87FCA4382BB7Q36310219-5D82FF32-7B87-4E04-A2D3-705AB8CBAEF1Q37334404-2C1D706F-8234-4D94-8AFB-775A903EC3F6Q38434399-0DB6FA7F-2EBE-499A-8D0A-4E319BC6D0A6Q38668625-FCD72722-727F-49F8-9D4A-E3A47D486582Q38691377-21E76A53-DFFD-4C32-B676-809B2F7B3A53Q38692457-041EE32D-E0C0-4ACB-9A6A-13A15761D355Q38771703-8318449B-46DE-46EF-9BA4-9ECB1B0C38A3Q38837561-E499CC6E-F47E-464F-98D6-064AE426A0D4Q38987705-D9018562-B7A3-44D5-8982-1B80133B1194Q39809867-FE37054C-E987-4084-9552-8C363F2BB88DQ40173008-C3CE9EA4-6732-4673-9CA2-8A1796BAEB0CQ41583442-3FFA07E8-3EA4-400A-82FC-50F213D8CFA9Q42540410-A3014EC6-2F60-4306-883E-B3609C643738Q43110873-5C55B846-246E-4569-860E-763C181C54AFQ47128083-FAC63E4D-4568-4C38-83E1-EBDC5E6B4728Q48808733-F840D49E-5FAD-4674-BAA2-8ADD6C251319Q51023008-F7116CBC-AC33-4E29-BEFC-FC92D6C5F385Q52598516-45A166CC-54CF-44CF-8639-614450F46B72Q53789282-2F4CADF2-C83F-4C89-9ACD-3992C8D1131AQ54933469-CD53378E-FC39-448D-BEA5-DC49EED877CCQ55098311-C398ADC7-C912-432E-8A6F-85526E996004Q56951623-AF80D9B8-018D-461E-B5ED-63E62929867AQ57826915-6F253989-3C65-43DD-8ADC-9FBDD3C383F9
P2860
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@ast
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@en
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@nl
type
label
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@ast
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@en
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@nl
prefLabel
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@ast
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@en
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@nl
P2093
P2860
P50
P356
P1476
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains
@en
P2093
Brian D Marsden
Chris Wells
Clarence Yapp
Hannah Lingard
Ildiko Felletar
Martin Philpott
Octovia P Monteiro
Oleg Fedorov
Paul E Brennan
Sarah J Martin
P2860
P304
P356
10.1021/JM401568S
P407
P577
2013-12-30T00:00:00Z